IDC Unveils TechMatch: Revolutionizing Enterprise Software Selection with AI

NEEDHAM, Mass.--(BUSINESS WIRE)--Feb 27, 2025--

IDC, the trusted technology intelligence provider, today announced the launch of IDC TechMatch™. This groundbreaking AI-powered software sourcing platform marks a significant advancement in the way organizations evaluate and select enterprise software solutions. Powered by IDC's industry-leading technology research and data, TechMatch streamlines the software buying journey, reducing what once took months to weeks.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250227875174/en/

Recent IDC research reveals a critical challenge: 44% of CIOs cite the high costs and complexities of sourcing as their top concern in 2024. 1 To tackle this head-on, TechMatch leverages decades of data gathered from IDC’s award-winning global research teams to instantly deliver AI-driven recommendations tailored to each organization's unique needs, providing a more streamlined and lower-risk approach to software selection.

Oftentimes, software selection is a fragmented process, dependent on web searches, marketing materials, peer reviews, time-consuming product demos, and a multitude of spreadsheets. And it can be an expensive and people intensive process involving lengthy consulting assignments.

Phil Carter, vice president and general manager of Tech Buyer Digital Platform Research at IDC, remarked, "Software sourcing has been slow to evolve in a rapidly advancing IT landscape. TechMatch addresses this gap by making IDC’s comprehensive vendor research instantly accessible and actionable through AI."

According to IDC, 88% of IT executives agree that AI will positively impact software sourcing and vendor selection. 2 IDC TechMatch delivers:

"IDC has identified a critical challenge that mid-sized companies like ours often face: we need to make technology solution acquisition decisions quickly, but without a dedicated team to evaluate markets, technologies, and platforms, we're drowning in research and vendor calls," said Ashley Spicer, CIO, AMAROK. "Using IDC TechMatch, our team can work from a shared foundation of trusted information and focus on the solutions that actually fit our requirements. This eliminates months of research and demos, enabling us to avoid costly mistakes, select optimal solutions for our business, and keep pace with rapidly evolving technology."

The launch of TechMatch comes at a crucial time. With mid-sized businesses managing around 150 applications and large enterprises handling thousands, the traditional months-long software evaluation process is no longer sustainable. A poor software decision can have significant consequences, as these choices become deeply embedded in organizational workflows.

“Artificial Intelligence has brought the world fundamental new capabilities in reducing cost, accelerating results, and producing better outcomes,” said Jim Spare, senior vice president & general manager, IDC TechMatch. “With IDC TechMatch, we’re combining this powerful new technology with our proprietary data to give any company the ability to transform how they approach software sourcing and selection.”

IDC will showcase TechMatch at its upcoming Directions conference for technology leaders, on April 2 in San Jose, CA. At this year’s conference, attendees can hear from leading IDC analysts on AI-fueled business strategies and receive a demo of TechMatch.

To explore how TechMatch can optimize your software sourcing strategy, visit the IDC Blog.

About IDC

International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets. With more than 1,300 analysts worldwide, IDC offers global, regional, and local expertise on technology, IT benchmarking and sourcing, and industry opportunities and trends in over 110 countries. IDC's analysis and insight helps IT professionals, business executives, and the investment community to make fact-based technology decisions and to achieve their key business objectives. Founded in 1964, IDC is a wholly owned subsidiary of International Data Group ( IDG ), the world's leading tech media, data, and marketing services company. To learn more about IDC, please visit www.idc.com. Follow IDC on Twitter at @IDC and LinkedIn. Subscribe to the IDC Blog for industry news and insights.

 

IDC, the trusted technology intelligence provider, today announced the launch of IDC TechMatch™, the first AI-powered platform with built-in market intelligence to streamline software sourcing, enhancing decision-making for organizations. Powered by IDC's industry-leading technology research and data, TechMatch streamlines the software buying journey, reducing what once took months to weeks. (Graphic: Business Wire)

LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.

Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.

In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”

Here’s what to know about the king's condition and his message.

The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”

He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.

“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”

Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.

“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”

Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.

The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.

The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.

Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.

Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.

British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.

Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.

The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”

Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”

“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.

The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.

Find more of AP’s coverage at https://apnews.com/hub/royalty

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)